Fred Alger Management LLC purchased a new position in shares of Enovix Co. (NASDAQ:ENVX – Free Report) during the second quarter, Holdings Channel reports. The institutional investor purchased 22,916 shares of the company’s stock, valued at approximately $354,000.
A number of other institutional investors also recently added to or reduced their stakes in the stock. Arizona State Retirement System boosted its position in Enovix by 2.3% during the second quarter. Arizona State Retirement System now owns 40,097 shares of the company’s stock valued at $620,000 after purchasing an additional 905 shares in the last quarter. Corient Private Wealth LLC boosted its position in Enovix by 1.9% during the fourth quarter. Corient Private Wealth LLC now owns 49,587 shares of the company’s stock valued at $621,000 after purchasing an additional 910 shares in the last quarter. Blue Trust Inc. boosted its position in Enovix by 102.1% during the second quarter. Blue Trust Inc. now owns 1,894 shares of the company’s stock valued at $29,000 after purchasing an additional 957 shares in the last quarter. Voisard Asset Management Group Inc. boosted its position in Enovix by 25.0% during the second quarter. Voisard Asset Management Group Inc. now owns 5,000 shares of the company’s stock valued at $77,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its position in Enovix by 7.7% during the second quarter. Principal Financial Group Inc. now owns 20,079 shares of the company’s stock valued at $310,000 after purchasing an additional 1,434 shares in the last quarter. Institutional investors own 50.92% of the company’s stock.
Enovix Price Performance
NASDAQ:ENVX opened at $9.55 on Friday. The company has a quick ratio of 3.84, a current ratio of 3.98 and a debt-to-equity ratio of 0.97. The company has a market capitalization of $1.68 billion, a P/E ratio of -7.12 and a beta of 1.99. Enovix Co. has a 52 week low of $5.70 and a 52 week high of $18.68. The stock’s fifty day moving average is $10.53 and its two-hundred day moving average is $10.51.
Analysts Set New Price Targets
ENVX has been the subject of several recent analyst reports. TD Cowen raised their price target on Enovix from $11.00 to $14.00 and gave the stock a “hold” rating in a report on Thursday, August 1st. Benchmark initiated coverage on Enovix in a report on Monday, July 22nd. They issued a “buy” rating and a $25.00 price target for the company. Craig Hallum raised their price target on Enovix from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. B. Riley raised Enovix to a “strong-buy” rating in a report on Tuesday, June 25th. Finally, Canaccord Genuity Group raised their price target on Enovix from $17.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. One analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $21.33.
View Our Latest Report on Enovix
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
- Five stocks we like better than Enovix
- Stock Market Sectors: What Are They and How Many Are There?
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- What Are Dividend Champions? How to Invest in the Champions
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Best Aerospace Stocks Investing
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.